Compare AANJANEYA LIFECARE with Orchid Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs ORCHID PHARMA LTD - Comparison Results

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS ORCHID PHARMA LTD DR. DATSONS LABS/
ORCHID PHARMA LTD
 
P/E (TTM) x -10.9 -0.5 - View Chart
P/BV x 0.2 0.1 137.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 DR. DATSONS LABS   ORCHID PHARMA LTD
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
ORCHID PHARMA LTD
Sep-13
DR. DATSONS LABS/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs126194 64.7%   
Low Rs3135 88.3%   
Sales per share (Unadj.) Rs133.0276.5 48.1%  
Earnings per share (Unadj.) Rs0.2-79.2 -0.2%  
Cash flow per share (Unadj.) Rs6.6-43.5 -15.2%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs128.853.9 238.8%  
Shares outstanding (eoy) m31.6670.45 44.9%   
Bonus/Rights/Conversions FCCBESOP-  
Price / Sales ratio x0.60.4 142.1%   
Avg P/E ratio x516.1-1.4 -35,704.7%  
P/CF ratio (eoy) x11.8-2.6 -449.4%  
Price / Book Value ratio x0.62.1 28.6%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,4778,067 30.7%   
No. of employees `000NA2.8 0.0%   
Total wages/salary Rs m562,527 2.2%   
Avg. sales/employee Rs ThNM6,956.1-  
Avg. wages/employee Rs ThNM902.5-  
Avg. net profit/employee Rs ThNM-1,993.0-  
INCOME DATA
Net Sales Rs m4,21119,477 21.6%  
Other income Rs m79407 19.3%   
Total revenues Rs m4,28919,884 21.6%   
Gross profit Rs m5691,103 51.6%  
Depreciation Rs m2042,519 8.1%   
Interest Rs m4305,227 8.2%   
Profit before tax Rs m13-6,236 -0.2%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m6-125 -4.9%   
Profit after tax Rs m5-5,580 -0.1%  
Gross profit margin %13.55.7 238.5%  
Effective tax rate %48.02.0 2,392.4%   
Net profit margin %0.1-28.7 -0.4%  
BALANCE SHEET DATA
Current assets Rs m6,85211,014 62.2%   
Current liabilities Rs m6,71132,060 20.9%   
Net working cap to sales %3.3-108.1 -3.1%  
Current ratio x1.00.3 297.2%  
Inventory Days Days16195 169.5%  
Debtors Days Days31834 949.1%  
Net fixed assets Rs m3,67329,440 12.5%   
Share capital Rs m317705 44.9%   
"Free" reserves Rs m3,7612,043 184.1%   
Net worth Rs m4,0783,800 107.3%   
Long term debt Rs m1,6719,018 18.5%   
Total assets Rs m12,63346,510 27.2%  
Interest coverage x1.0-0.2 -533.1%   
Debt to equity ratio x0.42.4 17.3%  
Sales to assets ratio x0.30.4 79.6%   
Return on assets %3.4-0.8 -453.1%  
Return on equity %0.1-146.9 -0.1%  
Return on capital %7.7-3.7 -205.5%  
Exports to sales %22.937.9 60.4%   
Imports to sales %14.322.6 63.2%   
Exports (fob) Rs m9647,378 13.1%   
Imports (cif) Rs m6024,406 13.7%   
Fx inflow Rs m9647,513 12.8%   
Fx outflow Rs m6075,649 10.7%   
Net fx Rs m3571,865 19.1%   
CASH FLOW
From Operations Rs m1,3451,682 80.0%  
From Investments Rs m-2,256-9,860 22.9%  
From Financial Activity Rs m-1,2006,644 -18.1%  
Net Cashflow Rs m-2,111-1,535 137.5%  

Share Holding

Indian Promoters % 4.5 32.3 14.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 4.6 -  
FIIs % 1.4 3.3 40.9%  
ADR/GDR % 0.0 4.6 -  
Free float % 94.1 55.3 170.2%  
Shareholders   20,807 84,811 24.5%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   GSK PHARMA  ASTRAZENECA PHARMA  BIOCON   PIRAMAL ENTERPRISES  JUBILANT LIFE SCIENCES  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Economic Growth and Stock Markets: It's Not All Gloom and Doom(Podcast)

In addition to the usual stock market updates of the week, I talk about how RBI's monetary policy decision and slowing economy impacts you and your portfolio of stocks.

Related Views on News

ORCHID PHARMA LTD Announces Quarterly Results (2QFY19); Net Profit Up 67.1% (Quarterly Result Update)

Jan 31, 2019 | Updated on Jan 31, 2019

For the quarter ended September 2018, ORCHID PHARMA LTD has posted a net profit of Rs 231 m (up 67.1% YoY). Sales on the other hand came in at Rs 1 bn (down 31.9% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

ORCHID PHARMA LTD Announces Quarterly Results (4QFY18); Net Profit Up 50.8% (Quarterly Result Update)

Aug 24, 2018 | Updated on Aug 24, 2018

For the quarter ended March 2018, ORCHID PHARMA LTD has posted a net profit of Rs 924 m (up 50.8% YoY). Sales on the other hand came in at Rs 2 bn (down 24.0% YoY). Read on for a complete analysis of ORCHID PHARMA LTD's quarterly results.

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

Hindustan Aeronautics IPO: Yet Another Play on India's Defence Sector (IPO)

Mar 14, 2018

Should you apply for the IPO of state-run military aircraft maker Hindustan Aeronautics?

More Views on News

Most Popular

Could this Smallcap Be the Next Page Industries?(Profit Hunter)

Nov 27, 2019

A single stock - Coca Cola, made Buffett billions. Here's your chance to break into the crorepati club with a single smallcap stock investment.

How We Made 12.68% in One Overnight Trade(The 5 Minute Wrapup)

Nov 25, 2019

This one trade had my subscribers laughing all the way to the bank.

Growth Stocks or Value Stocks... What Will Make You More Money in this Bull Market?(Profit Hunter)

Nov 28, 2019

Should you invest in growth stocks or value stocks to make strong returns in this market?

Two Trends to Look at as Sensex Crosses 41,000 Levels(Views On News)

Nov 26, 2019

The two trends that are playing out as Sensex touches new record high.

The Best Trading Strategy for Fast Profits

Nov 29, 2019

Vijay and I have decided to team up and bring you a unique offering never seen before in the Indian stock markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS 8-QTR ANALYSIS

COMPARE DR. DATSONS LABS WITH

MARKET STATS